In addition to the inhibition of EGFR activation, the anti-tumor effect of cetuximab is mediated by antibody-dependent cell-mediated cytotoxicity12,21,22, hypoxic tumor microenvironment induced drug resistance23, and inhibition of epithelial–mesenchymal transition24. Here, EGFR is linked to neoplasm.